geko
Commercial- Indications
- Deep vein thrombosis prevention, Post-operative edema, Trauma-based edema, Chronic wound healing, Leg ulcers
Company intelligence / Profile preview
The company’s lead product, the geko® device using OnPulse™ technology, has demonstrated clinical utility in improving blood flow and reducing complications such as deep vein thrombosis and post-operative edema. It has been adopted in multiple clinical settings with published evidence supporting its efficacy for vascular-related indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Firstkind.